SAN DIEGO, Jan. 27, 2021 /PRNewswire/ -- ViaCyte, Inc., a clinical-stage regenerative medicine company, today announced the appointment of Michael Yang to President and CEO and as a member of ViaCyte's Board of Directors. The Company also appointed Steve White, BSc Pharm, as Chief Technology Officer, and promoted Brittany Bradrick, who joined ViaCyte in July 2020 as Chief Financial […]
